Label: SODIUM CHLORIDE injection, solution

  • NDC Code(s): 65282-1505-1, 65282-1510-1
  • Packager: Spectra Medical Devices, Inc.
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated November 18, 2019

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    0.9% Sodium Chloride
    Injection, USP

    Rx only

  • DESCRIPTION

    This preparation is designed solely for parenteral use only after addition of drugs that require dilution or must be dissolved in an aqueous vehicle prior to injection.

    0.9% Sodium Chloride Injection, USP is a sterile, nonpyrogenic, isotonic solution of sodium chloride and water for injection. Each mL contains sodium chloride 9 mg. It contains no bacteriostat, antimicrobial agent or added buffer and is supplied only in single-dose containers to dilute or dissolve drugs for injection. 0.308 mOsmol/mL (calc.). 0.9% Sodium Chloride Injection, USP contains no preservatives. The solution may contain hydrochloric acid and/or sodium hydroxide for pH adjustment. The pH range is 4.5 to 7.0. The glass ampules made up of Type I glass are used as a primary container for the drug product.

    Sodium Chloride, USP is chemically designated NaCl, a white crystalline compound freely soluble in water.

  • CLINICAL PHARMACOLOGY

    Sodium chloride in water dissociates to provide sodium (Na +) and chloride (Cl -) ions. These ions are normal constituents of the body fluids (principally extracellular) and are essential for maintaining electrolyte balance.

    The distribution and excretion of sodium (Na +) and chloride (Cl -) are largely under the control of the kidney which maintains a balance between intake and output.

    The small volume of fluid and amount of sodium chloride provided by 0.9% Sodium Chloride Injection, USP when used only as an isotonic vehicle for parenteral injection of drugs, is unlikely to exert a significant effect on fluid and electrolyte balance except possibly in neonates and very small infants.

    Water is an essential constituent of all body tissues and accounts for approximately 70% of total body weight. Average normal adult daily requirement ranges from two to three liters (1.0 to 1.5 liters each for insensible water loss by perspiration and urine production).

    Water balance is maintained by various regulatory mechanisms. Water distribution depends primarily on the concentration of electrolytes in the body compartments and sodium (Na+) plays a major role in maintaining physiologic equilibrium.

  • INDICATIONS AND USAGE

    This parenteral preparation is indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered.

  • PRECAUTIONS

    Consult the manufacturer's instructions for choice of vehicle, appropriate dilution or volume for dissolving the drugs to be injected, including the route and rate of injection.

    Inspect reconstituted (diluted or dissolved) drugs for clarity (if soluble) and freedom from unexpected precipitation or discoloration prior to administration.

    Pregnancy Category C

    Animal reproduction studies have not been conducted with 0.9% Sodium Chloride Injection, USP. It is also not known whether sodium chloride injection containing additives can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Sodium chloride injection containing additives should be given to a pregnant woman only if clearly needed.

    Pediatric Use

    The safety and effectiveness in the pediatric population are based on the similarity of the clinical conditions of the pediatric and adult populations. In neonates or very small infants the volume of fluid may affect fluid and electrolyte balance.

    Drug Interactions

    Some drugs for injection may be incompatible in a given vehicle, or when combined in the same vehicle or in a vehicle containing benzyl alcohol. Consult with pharmacist, if available.

    Use aseptic technique for single or multiple entry and withdrawal from all containers.

    When diluting or dissolving drugs, mix thoroughly and use promptly.

    Do not store reconstituted solutions of drugs for injection unless otherwise directed by the manufacturer of the solute.

    Do not use unless the solution is clear and seal intact. Do not reuse single-dose containers, discard unused portion.

  • ADVERSE REACTIONS

    Reactions which may occur because of this solution, added drugs or the technique of reconstitution or administration include febrile response, local tenderness, abscess, tissue necrosis or infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection and extravasation.

    If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate countermeasures, and if possible, retrieve and save the remainder of the unused vehicle for examination.

  • OVERDOSAGE

    Use only as a diluent or solvent. This parenteral preparation is unlikely to pose a threat of carbohydrate, sodium chloride or fluid overload except possibly in neonates or very small infants. In the event these should occur, re-evaluate the patient and institute appropriate corrective measures. See PRECAUTIONS and ADVERSE REACTIONS.

  • DOSAGE AND ADMINISTRATION

    The volume of the preparation to be used for diluting or dissolving any drug for injection, is dependent on the vehicle concentration, dose and route of administration as recommended by the manufacturer.

    This parenteral should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. See PRECAUTIONS.

  • HOW SUPPLIED

    0.9% Sodium Chloride Injection, USP is supplied in the following:

    SizeContainerNDC
    5 mLGlass ampules packaged in carton of 25 each65282-1505-1
    10 mLGlass ampules packaged in carton of 25 each65282-1510-1

    Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature].

    Manufactured for:

    Spectra Medical Devices, Inc.

    260-F Fordham Road

    Wilmington, MA 01887

    By:

    Kwang Myung Pharm Co., Ltd

    957, Wangam-dong

    Jechon

    Chungbuk 27159

    Republic of Korea

    XX#### Rev. #

    MM/YY

  • Principal Display Panel - 5 mL Carton Label

    Rx only

    25 Single-dose ampules

    Each single-dose ampule contains 5 mL NDC 65282-1505-1

    0.9% Sodium Chloride Injection, USP

    Each mL contains sodium chloride, 9 mg in water for injection. The solution may contain hydrochloric acid and/or sodium hydroxide for pH adjustment. The pH range is 4.5 to 7.0. 0.308 mOsmol/mL (calc).

    FOR USE AS A STERILE DILUENT

    For additional information, see package insert.

    Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F)
    [See USP Controlled Room Temperature],

    PRESERVATIVE-FREE

    To open ampules, using gauze, place thumb and forefinger on color line, break at constriction.

    Product Code: XXXX-Y

    MANUFACTURED FOR: SPECTRA MEDICAL DEVICES, INC. WILMINGTON, MA. 01887 BY: K.M. PHARM. CO., LTD. Jecheon, Korea 27159

    Principal Display Panel - 5 mL Carton Label
  • Principal Display Panel - 5 mL Ampule Label

    NDC 65282-1505-1

    5mL Ampule

    0.9% Sodium Chloride Injection, USP

    0.308 mOsmol/mL (calc)

    Rx only Single-dose

    FOR USE AS A STERILE DILUENT

    PRESERVATIVE-FREE

    Each mL contains sodium chloride, 9 mg. The solution may contain hydrochloric acid and/or sodium hydroxide for pH adjustment.

    The pH range is 4.5 to 7.0.

    MANUFACTURED FOR:

    Spectra Medical Devices, Inc.

    Wilmington, MA 01887 By:

    K.M. Pharm. co., Ltd.

    Jecheon, Korea 27159

    To open ampules, using gauze, place thumb and forefinger on color line, break at constriction.

    Product Code: XXXX-Y

    Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F)
    [See USP Controlled Room Temperature].

    LOT No.: KXXXXXXX

    EXP.: MM/YYYY

    Principal Display Panel - 5 mL Ampule Label
  • Principal Display Panel - 10 mL Carton Label

    Rx only

    25 Single-dose ampules

    Each single-dose ampule contains 10 mL NDC 65282-1510-1

    0.9% Sodium Chloride Injection, USP

    Each mL contains sodium chloride, 9 mg in water for injection. The solution may contain hydrochloric acid and/or sodium hydroxide for pH adjustment. The pH range is 4.5 to 7.0. 0.308 mOsmol/mL (calc).

    FOR USE AS A STERILE DILUENT

    For additional information, see package insert.

    Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F)
    [See USP Controlled Room Temperature].

    PRESERVATIVE-FREE

    To open ampules, using gauze, place thumb and forefinger on color line, break at constriction.

    Product Code: XXXX-Y

    MANUFACTURED FOR: SPECTRA MEDICAL DEVICES, INC. WILMINGTON, MA. 01887

    BY : K.M. PHARM. CO., LTD. Jecheon, Korea 27159

    Principal Display Panel - 10 mL Carton Label
  • Principal Display Panel - 10 mL Ampule Label

    NDC 65282-1510-1

    10 mL Ampule

    0.9% Sodium Chloride Injection, USP

    0.308 mOsmol/mL (calc)

    Rx only Single-dose

    FOR USE AS A STERILE DILUENT

    PRESERVATIVE-FREE

    Each mL contains sodium chloride, 9 mg.

    The solution may contain hydrochloric acid and/or sodium hydroxide for pH adjustment.

    The pH range is 4.5 to 7.0.

    MANUFACTURED FOR:

    Spectra Medical Devices, Inc.

    Wilmington, MA 01887 By:

    K.M. Pharm. co., Ltd.

    Jecheon, Korea 27159

    To open ampules, using gauze, place thumb and forefinger on color line, break at constriction.

    Product Code: XXXX-Y

    Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F)
    [See USP Controlled Room Temperature].

    LOT No.: KXXXXXXX

    EXP.: MM/YYYY

    Principal Display Panel - 10 mL Ampule Label
  • INGREDIENTS AND APPEARANCE
    SODIUM CHLORIDE 
    sodium chloride injection, solution
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:65282-1505
    Route of AdministrationINTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) (CHLORIDE ION - UNII:Q32ZN48698) SODIUM CHLORIDE9 mg  in 1 mL
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:65282-1505-15 in 1 CARTON07/21/2017
    15 in 1 TRAY
    15 mL in 1 AMPULE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA20617107/21/2017
    SODIUM CHLORIDE 
    sodium chloride injection, solution
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:65282-1510
    Route of AdministrationINTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) (CHLORIDE ION - UNII:Q32ZN48698) SODIUM CHLORIDE9 mg  in 1 mL
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:65282-1510-15 in 1 CARTON07/21/2017
    15 in 1 TRAY
    110 mL in 1 AMPULE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA20617107/21/2017
    Labeler - Spectra Medical Devices, Inc. (926980624)
    Establishment
    NameAddressID/FEIBusiness Operations
    Huons Co., Ltd_Jecheon Factory1631099384manufacture(65282-1505, 65282-1510)